BNGO250117P500
- 0.29
- 0.000.00%
Bionano Genomics Newsroom
Bionano Announces Publication Showing That OGM Identifies Variant That Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia
Bionano Genomics Closes $10 Million Offering of Shares, Warrants
Investors Still Aren't Entirely Convinced By Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues Despite 33% Price Jump
Bionano Genomics Files to Sell 50.56M Share of Common Stock for Holders
12 Health Care Stocks Moving In Friday's Pre-Market Session
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
Bionano Stock Rallies 19% on ATM Direct Offering
Press Release: Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BioNano Genomics Restructures Debt to Boost Liquidity
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring That Improves Cash Runway
Bionano Announces Publication From Johns Hopkins School of Medicine Showing That OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
Bionano Genomics Announces Presentations at ASH Annual Meeting
Express News | Bionano Announces Presentations at the American Society of Hematology (Ash) Annual Meeting That Underscore Ogm Utility Across Blood Cancer Research and Cell & Gene Therapy
Hold Rating on BioNano Genomics Amid Revenue Shortfall and Strategic Shift
Bionano Genomics Analyst Ratings
Scotiabank Maintains Bionano Genomics(BNGO.US) With Hold Rating, Maintains Target Price $1
Scotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)
Ladenburg Thalmann Downgrades Bionano Genomics(BNGO.US) to Hold Rating